Leite-Morris Kimberly A, Fukudome Eugene Y, Kaplan Gary B
Research Service, Veterans Affairs Medical Center, Providence, RI 02908, USA.
Neurosci Lett. 2002 Jan 14;317(3):119-22. doi: 10.1016/s0304-3940(01)02457-0.
Recent studies suggest that gamma-aminobutyric acid type B (GABA(B)) receptors located on dopaminergic cells in the ventral tegmental area (VTA) regulate mesolimbic dopaminergic (A10) activity. In the current study, we identified GABA(B) receptor subtypes in the area of the VTA and examined their role in modulating acute opiate actions. We studied the effects of intra-VTA infusions of the selective GABA(B) agonist baclofen on morphine-induced locomotor stimulation and A10 neuronal activation. Drug treatments were followed by ambulatory activity monitoring for 180 min. Intra-VTA baclofen treatment produced a 70% inhibition of morphine-stimulated locomotor activity. Furthermore, functional activation of A10 neurons was assessed by immunohistochemical staining of c-Fos in the nucleus accumbens (NAc), where A10 neurons terminate. We found that morphine treatment increased the levels of Fos-positive nuclei in the NAc, while intra-VTA baclofen treatment reversed morphine's effects. Finally, GABA(B) receptor subtypes and isoforms were identified in the ventromedial mesencephalon using immunoblotting. We demonstrated the presence of GABA(B)R1a (130 kDa), GABA(B)R1b (100 kDa), and GABA(B)R2 (120 kDa) receptor subtypes in this region. These results suggest that GABA(B) receptor isoforms are found in the VTA and their activation results in the blockade of behavioral effects of opiates via inhibition of dopaminergic neurotransmission.
最近的研究表明,位于腹侧被盖区(VTA)多巴胺能细胞上的γ-氨基丁酸B型(GABA(B))受体调节中脑边缘多巴胺能(A10)活性。在本研究中,我们确定了VTA区域中的GABA(B)受体亚型,并研究了它们在调节急性阿片类药物作用中的作用。我们研究了向VTA内注射选择性GABA(B)激动剂巴氯芬对吗啡诱导的运动刺激和A10神经元激活的影响。药物处理后,进行180分钟的动态活动监测。向VTA内注射巴氯芬可使吗啡刺激的运动活性受到70%的抑制。此外,通过对A10神经元终末所在的伏隔核(NAc)中c-Fos进行免疫组织化学染色来评估A10神经元的功能激活。我们发现,吗啡处理可增加NAc中Fos阳性细胞核的水平,而向VTA内注射巴氯芬可逆转吗啡的作用。最后,使用免疫印迹法在腹内侧中脑鉴定了GABA(B)受体亚型和异构体。我们证明了该区域存在GABA(B)R1a(130 kDa)、GABA(B)R1b(100 kDa)和GABA(B)R2(120 kDa)受体亚型。这些结果表明,GABA(B)受体异构体存在于VTA中,其激活通过抑制多巴胺能神经传递导致阿片类药物行为效应的阻断。